You'll like this correction!!!...
"The NIH AIDS Reagent Program owns PGT121, a broadly neutralizing antibody (bNAb) being developed to treat HIV."
Didn't realize i was looking @ an older link showing Janssen, Gilead & another company.
NIH owns PGT
(4)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-